section name header

Evidence summaries

Histamine H2-Receptor Antagonists for Urticaria.

There is insufficient evidence about the use of H2-receptor antagonists for urticaria Level of evidence: "D"

The quality of evidence is downgraded because of study limitations (several issues) and imprecise results (few patients).

Summary

A Cochrane review [Abstract] 1 included 4 studies with a total of 144 subjects. A combination of ranitidine with diphenhydramine was more effective at improving the resolution of urticaria than diphenhydramine administered alone (RR 1.59, 95% CI 1.07 to 2.36). Although there was a similar improvement in itching, weal size, and intensity, cimetidine provided no statistically significant greater overall improvement in symptoms of urticaria when compared to diphenhydramine. However, a combination of these medications was more effective than diphenhydramine alone (RR 2.02, 95% CI 1.03 to 3.94). Adverse events were reported with several of the interventions, i.e. ranitidine and diphenhydramine, causing drowsiness and sedation, but there was no significant difference in the level of sedation from baseline with either famotidine or diphenhydramine.

Clinical comments

Note

Date of latest search: 2011-10-07

    References

    • Fedorowicz Z, van Zuuren EJ, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev 2012;3():CD008596. [PubMed]

Primary/Secondary Keywords